Tobacco Use in Pregnancy Intervention for Cessation (ToPIC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03442530|
Recruitment Status : Active, not recruiting
First Posted : February 22, 2018
Last Update Posted : March 19, 2019
|Condition or disease||Intervention/treatment||Phase|
|Pregnancy||Behavioral: ToPIC Behavioral: Tobacco Treatment As Usual (TTAU)||Not Applicable|
The purpose of this pilot project is to test effectiveness of a tobacco-treatment cessation intervention (American College of Obstetricians and Gynecologists (ACOG) 5 A's) through use of a non-physician healthcare champion from within the clinic's existing infrastructure. This Tobacco use in Pregnancy Intervention for Cessation (ToPIC) will involve training the identified healthcare provider to become a Certified Tobacco Treatment Specialist (CTTS) and to administer the 5 A's to pregnant Medicaid patients receiving prenatal care through two high-volume Kentucky obstetrics clinics. This trial will provide evidence to evaluate this approach to delivering an established intervention in clinical practice.
The Investigators propose to test the effectiveness of the clinical intervention by using a two-armed cluster randomized controlled design. Eligible participants will be randomized to the intervention (ToPIC) or standard of care for smoking cessation in pregnancy. This pilot project will gather quantitative and qualitative data for a mixed-method, multi-stakeholder process evaluation of intervention training and delivery. Furthermore, the Investigators' use of Medicaid claims data to examine healthcare utilization outside of maternal and infant well-care visits will enhance understanding of the strengths and limitations of these data for future evaluations. This study has the potential to significantly impact the most vulnerable in Kentucky, where rates of tobacco use among pregnant women are among the highest in the nation.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||120 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Tobacco Use in Pregnancy Intervention for Cessation|
|Actual Study Start Date :||January 22, 2018|
|Actual Primary Completion Date :||February 15, 2019|
|Estimated Study Completion Date :||December 2019|
Active Comparator: Tobacco Treatment As Usual (TTAU)
Eligible women assigned to the control group will be informed of the risks of tobacco use and benefits of quitting using the ACOG 5A's approach by their healthcare provider.5 This standard takes approximately 5-15 minutes, and is offered at each prenatal and postpartum appointment. The study coordinator will invite participants to complete the tobacco use questionnaires (TUQ),urine cotinine validation, and Expired Air Carbon Monoxide (EACO) analysis to assess ongoing tobacco use at the designated time points.
Behavioral: Tobacco Treatment As Usual (TTAU)
Standard of care tobacco cessation counseling for pregnant women
Eligible women assigned to the intervention will receive TTAU plus ToPIC administered by the CTTS. At least once monthly, at routinely scheduled prenatal visits or through telephone, the CTTS will provide cessation counseling. The CTTS will invite participants to complete TUQs,urine cotinine validation and EACO analysis to assess ongoing tobacco use at the designated time points.
Expanded tobacco cessation counseling for pregnant women.
- Smoking cessation [ Time Frame: Baseline to third trimester ]Change in urine cotinine level
- Number of cigarettes per day [ Time Frame: Baseline to third trimester ]Self-reported change in number of cigarettes smoked per day
- Smoking cessation after delivery [ Time Frame: Prior to delivery hospitalization discharge, estimated 3 days ]Self-report smoking cessation
- Infant birth weight [ Time Frame: At time of delivery ]Infant weight measured in grams
- Gestational age [ Time Frame: At time of delivery ]Weeks of gestation at delivery
- Health care utilization outside of well-visits [ Time Frame: Birth to 6 months ]Maternal and infant visits for non-routine healthcare
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03442530
|United States, Kentucky|
|University of Kentucky College of Nursing|
|Lexington, Kentucky, United States, 40536|
|Principal Investigator:||Kristin Ashford||University of Kentucky|